Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
06 06 2022
06 06 2022
Historique:
received:
29
03
2022
accepted:
05
04
2022
entrez:
6
6
2022
pubmed:
7
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
Coronavirus disease 2019 (COVID-19) affects people of any age with high mortality and morbidity in adults older than 65 years. Reports on pediatric cases highlighted those children generally develop milder symptoms than adults or are asymptomatic. We aimed to assess the epidemiological and clinical data of children and adolescents with SARS-CoV-2 infection to improve pediatric COVID-19. We retrospectively analyzed clinical and epidemiological features of patients with SARS-CoV-2 infection hospitalized at the Pediatric Hospital of Pavia, Italy, between February 1, 2020, to April 30, 2021. 71 patients aged 0-16 years were included; 33 (46%) females and 38 (54 %) males. Thirty-three (46%) patients had comorbidities, such as obesity and hematological diseases. Thirty-one children (44%) were exposed to COVID-19-positive household members. Nine (12.7 %) patients were asymptomatic, whereas 57 (80.3%) had a mild-moderate disease. Only five (7%) showed a severe or critical disease, and two patients required ICU admission. The most frequent symptoms were fever (76%), loss of appetite (26%), gastrointestinal symptoms (19%), and cough (19%). Chest X-ray was performed in 42 patients showing lung abnormalities in more than half of symptomatic patients. The most common laboratory features were lymphopenia and eosinopenia associated with high levels of inflammation markers. This study confirmed that COVID-19 has a mild course in children compared to adults. Most of the enrolled children were asymptomatic or had a mild-moderate disease. Patients with comorbidities were more prone to develop clinical complications.
Sections du résumé
BACKGROUND
Coronavirus disease 2019 (COVID-19) affects people of any age with high mortality and morbidity in adults older than 65 years. Reports on pediatric cases highlighted those children generally develop milder symptoms than adults or are asymptomatic. We aimed to assess the epidemiological and clinical data of children and adolescents with SARS-CoV-2 infection to improve pediatric COVID-19.
METHODS
We retrospectively analyzed clinical and epidemiological features of patients with SARS-CoV-2 infection hospitalized at the Pediatric Hospital of Pavia, Italy, between February 1, 2020, to April 30, 2021.
RESULTS
71 patients aged 0-16 years were included; 33 (46%) females and 38 (54 %) males. Thirty-three (46%) patients had comorbidities, such as obesity and hematological diseases. Thirty-one children (44%) were exposed to COVID-19-positive household members. Nine (12.7 %) patients were asymptomatic, whereas 57 (80.3%) had a mild-moderate disease. Only five (7%) showed a severe or critical disease, and two patients required ICU admission. The most frequent symptoms were fever (76%), loss of appetite (26%), gastrointestinal symptoms (19%), and cough (19%). Chest X-ray was performed in 42 patients showing lung abnormalities in more than half of symptomatic patients. The most common laboratory features were lymphopenia and eosinopenia associated with high levels of inflammation markers.
CONCLUSIONS
This study confirmed that COVID-19 has a mild course in children compared to adults. Most of the enrolled children were asymptomatic or had a mild-moderate disease. Patients with comorbidities were more prone to develop clinical complications.
Identifiants
pubmed: 35666116
doi: 10.23750/abm.v93iS3.13074
pmc: PMC9494185
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2022039Références
JAMA. 2020 Aug 25;324(8):782-793
pubmed: 32648899
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
N Engl J Med. 2020 Jul 9;383(2):187-190
pubmed: 32356945
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
Allergy Asthma Proc. 2020 Nov 1;41(6):e80-e82
pubmed: 33109314
Ital J Pediatr. 2021 Mar 3;47(1):47
pubmed: 33658068
Acta Biomed. 2021 Nov 29;92(S7):e2021524
pubmed: 34842595
J Med Virol. 2021 Jan;93(1):424-433
pubmed: 32584487
Acta Biomed. 2020 Sep 15;91(11-S):e2020004
pubmed: 33004774
Curr Allergy Asthma Rep. 2021 Feb 25;21(2):13
pubmed: 33630167
Nat Med. 2022 May;28(5):1050-1062
pubmed: 35177862
Acta Biomed. 2021 Nov 29;92(S7):e2021522
pubmed: 34842592
Int J Environ Res Public Health. 2021 Jan 26;18(3):
pubmed: 33530624
J Med Virol. 2020 Nov;92(11):2332-2334
pubmed: 32410241
Pediatrics. 2020 Jun;145(6):
pubmed: 32179659
Expert Rev Respir Med. 2021 Oct;15(10):1303-1316
pubmed: 34056983
JAMA. 2020 Apr 14;323(14):1335
pubmed: 32181795
Obesity (Silver Spring). 2020 Aug;28(8):1369
pubmed: 32396994
Lancet. 2020 Jun 6;395(10239):1771-1778
pubmed: 32410760
Nat Rev Microbiol. 2021 Mar;19(3):141-154
pubmed: 33024307
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
Acta Paediatr. 2020 Jun;109(6):1082-1083
pubmed: 32212348